Keros Therapeutics (KROS) EBITDA Margin Growth (3y) (2022 - 2025)

Keros Therapeutics (KROS) EBITDA Margin Growth (3y) (2022 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin Growth (3y) (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-40,178.00
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	530.00
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Keros Therapeutics	378.54 Mn	91.14 Mn	-	-

Download Data